Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2253702 | 1.00 | — | — | |
| SCHEMBL170103 | 0.94 | — | — | |
| Water SCHEMBL15334116 | 0.89 | — | — | |
| Iodide SCHEMBL28076188 | 0.89 | — | — | |
| SCHEMBL4924329 | 0.67 | — | — | |
| SCHEMBL18056719 | 0.67 | — | — | |
| SCHEMBL14536618 | 0.63 | — | — | |
| SCHEMBL2755007 | 0.63 | — | — | |
| SCHEMBL2620819 | 0.63 | — | — | |
| Hydrochloric Acid SCHEMBL8519016 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117384063-A | Synthesis process and product of trimethylhydrazine | 东力（南通）化工有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-108129357-B | Preparation method of anamorelin intermediate | 上海医药工业研究院 | 2021-12-21 | — | — | CN | claimed |
| CN-108129357-A | The preparation method of anamorelin intermediate | 上海医药工业研究院 | 2018-06-08 | — | — | CN | claimed |
| CN-121949149-A | Industrial production method of key intermediate of alamoulin | 诚弘制药(威海)有限责任公司 | 2026-05-01 | — | — | CN | disclosed |
| CN-117384063-B | Synthesis process and product of trimethylhydrazine | 东力（南通）化工有限公司 | 2025-11-07 | — | — | CN | disclosed |
| CN-118184730-A | Polycyclic compounds and their use as ghrelin receptor agonists | 南京知和医药科技有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-115960080-B | Polycyclic compounds and their use as ghrelin receptor agonists | 南京知和医药科技有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-117384063-A | Synthesis process and product of trimethylhydrazine | 东力（南通）化工有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-116082437-A | Polycyclic compounds and their use as ghrelin receptor agonists | 石家庄迪斯凯威医药科技有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-115960080-A | Polycyclic compound and application thereof as ghrelin receptor agonist | 南京知和医药科技有限公司 | 2023-04-14 | — | — | CN | disclosed |
| CN-112759546-B | 3- (dimethylaminomethyl) piperidin-4-ol derivatives, their preparation and their pharmaceutical use | 复旦大学 | 2022-08-26 | — | — | CN | disclosed |
| CN-108129357-B | Preparation method of anamorelin intermediate | 上海医药工业研究院 | 2021-12-21 | — | — | CN | disclosed |
| CN-112759546-A | 3- (dimethylaminomethyl) piperidin-4-ol derivatives, their preparation and their pharmaceutical use | 复旦大学 | 2021-05-07 | — | — | CN | disclosed |
| CN-108129357-A | The preparation method of anamorelin intermediate | 上海医药工业研究院 | 2018-06-08 | — | — | CN | disclosed |
| CN-108129357-A | The preparation method of anamorelin intermediate | 上海医药工业研究院 | 2018-06-08 | — | — | CN | disclosed |
| CN-103664973-B | Spiro-oxindole compounds and their use as therapeutic agents | 泽农医药公司 | 2017-04-19 | — | — | CN | disclosed |